Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts
- PMID: 33223399
- DOI: 10.1016/j.numecd.2020.09.023
Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts
Abstract
Aim: Whether the relative risk of cancer incidence and mortality associated with diabetes has changed over time is unknown.
Data synthesis: On August 12th, 2020, we electronically searched for observational studies reporting on the association between diabetes and cancer. We estimated temporal trends in the relative risk of cancer incidence or mortality associated with diabetes and calculated the ratio of relative risk (RRR) comparing different periods. As many as 193 eligible articles, reporting data on 203 cohorts (56,852,381 participants; 3,735,564 incident cancer cases; 185,404 cancer deaths) and covering the period 1951-2013, were included. The relative risk of all-site cancer incidence increased between 1980 and 2000 [RRR 1990 vs.1980: (1.24; 95% CI: 1.16, 1.34); 2000 vs.1990: (1.23; 1.15, 1.31)] and stabilised thereafter at a relative risk of 1.2; the relative risk of all-site cancer mortality was constant at about 1.2 from 1980 to 2010. Both magnitudes and trends in relative risk varied across cancer sites: the relative risk of colorectal, female breast, and endometrial cancer incidence and pancreatic cancer mortality was constant during the observed years; it increased for bladder, stomach, kidney, and pancreatic cancer incidence until 2000; and decreased for liver while increased for prostate, colon and gallbladder cancer incidence after 2000.
Conclusions: Alongside the increasing prevalence of diabetes, the temporal patterns of the relative risk of cancer associated with diabetes may have contributed to the current burden of cancer in people with diabetes.
Keywords: Cancer; Diabetes; Relative risk; Systematic review; Trend analysis.
Copyright © 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest SL, KB, JKM, LH, AM, EI, TY, and FZ declare no conflict of interest relevant to this article. KK has received honoraria and research support from AstraZeneca, Boehringer Ingelheim, Germany, Eli Lilly, Janssen, Merck Sharp & Dohme, USA, Novartis, Novo Nordisk, Roche and Sanofi, France. MJD has acted as consultant, advisory board member and speaker for Novo Nordisk, Sanofi–Aventis, France, Lilly, Merck Sharp & Dohme, USA, Boehringer Ingelheim, Germany, AstraZeneca and Janssen, an advisory board member for Servier and as a speaker for Mitsubishi Tanabe Pharma Corporation and Takeda Pharmaceuticals International Inc. She has received grants in support of investigator and investigator–initiated trials from Novo Nordisk, Sanofi–Aventis, France, Lilly, Boehringer Ingelheim, Germany and Janssen.
Similar articles
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015.Diabetologia. 2020 Jan;63(1):75-84. doi: 10.1007/s00125-019-04991-x. Epub 2019 Sep 12. Diabetologia. 2020. PMID: 31511931
-
Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People.Diabetes Care. 2020 Sep;43(9):2313-2322. doi: 10.2337/dc20-0204. Diabetes Care. 2020. PMID: 32910779
-
Long-term all-cause and cardiovascular mortality following incident myocardial infarction in men and women with and without diabetes: Temporal trends from 1998 to 2009.Eur J Prev Cardiol. 2016 Aug;23(12):1273-81. doi: 10.1177/2047487316634279. Epub 2016 Feb 23. Eur J Prev Cardiol. 2016. PMID: 26907793
-
Effect of diabetes mellitus on survival in patients with gallbladder Cancer: a systematic review and meta-analysis.BMC Cancer. 2020 Jul 24;20(1):689. doi: 10.1186/s12885-020-07139-y. BMC Cancer. 2020. PMID: 32709224 Free PMC article.
Cited by
-
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.Eur Urol. 2023 Aug;84(2):191-206. doi: 10.1016/j.eururo.2023.04.021. Epub 2023 May 16. Eur Urol. 2023. PMID: 37202314 Free PMC article.
-
Skeletal muscle density performance for screening frailty in older adults with cancer and the impact of diabetes: The CARE Registry.J Geriatr Oncol. 2024 Jul;15(6):101815. doi: 10.1016/j.jgo.2024.101815. Epub 2024 Jun 18. J Geriatr Oncol. 2024. PMID: 38896951 Free PMC article.
-
[Impact of type 2 diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma].Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Dec 18;56(6):1089-1096. doi: 10.19723/j.issn.1671-167X.2024.06.023. Beijing Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39690775 Free PMC article. Chinese.
-
Cardiovascular Effects of Cumulative Doses of Radioiodine in Differentiated Thyroid Cancer Patients with Type 2 Diabetes Mellitus.Cancers (Basel). 2022 May 10;14(10):2359. doi: 10.3390/cancers14102359. Cancers (Basel). 2022. PMID: 35625965 Free PMC article.
-
Associations of diabetes and mortality among colorectal cancer patients from the Southern Community Cohort Study.Br J Cancer. 2024 Oct;131(6):1050-1059. doi: 10.1038/s41416-024-02787-4. Epub 2024 Jul 19. Br J Cancer. 2024. PMID: 39030444 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials